Frequent Service: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count(1376911 procedures/year)
Frequent Service: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count(1032904 procedures/year)
Frequent Service: Injection, certolizumab pegol, 1 mg (code may be used for standard insurance when drug administered under the direct supervision of a physician, not for use when drug is self administered)(983800 procedures/year)
Frequent Service: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count(813968 procedures/year)
Frequent Service: Injection, certolizumab pegol, 1 mg (code may be used for standard insurance when drug administered under the direct supervision of a physician, not for use when drug is self administered)(507600 procedures/year)
Frequent Service: Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month(429558 procedures/year)
Frequent Service: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count(829391 procedures/year)
Frequent Service: Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count(813964 procedures/year)
Frequent Service: Injection, certolizumab pegol, 1 mg (code may be used for standard insurance when drug administered under the direct supervision of a physician, not for use when drug is self administered)(241200 procedures/year)